Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Regulatory News (IXI)

Share Price Information for Ixico (IXI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.125
Bid: 8.00
Ask: 8.25
Change: 0.00 (0.00%)
Spread: 0.25 (3.125%)
Open: 8.125
High: 8.125
Low: 8.125
Prev. Close: 8.125
IXI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

13 Jan 2017 15:25

RNS Number : 1709U
IXICO plc
13 January 2017
 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

IXICO plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

x

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify): New issue of shares

x

3. Full name of person(s) subject to thenotification obligation: iii

IP Group plc

4. Full name of shareholder(s)  (if different from 3.):iv

See section 9

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

09 January 2017

6. Date on which issuer notified:

13 January 2017

7. Threshold(s) that is/are crossed orreached: vi, vii

Direct interests: 21% reached

Indirect interests: Unchanged

Combined direct and indirect interests: 24% reached

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

 

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary 1p

6,001,506

6,001,506

5,704,585

5,704,585

809,774

21.08%

2.99%

GB00BCLY7L40

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

6,514,359

24.07%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

Direct interests:

 

IP2IPO Limited: 5,704,585

 

IP2IPO Limited is a 100%-owned subsidiary of IP Group plc.

 

 

Indirect interests:

 

North East Technology Fund - 809,774

 

North East Technology Fund is a limited partnership fund that is managed by Top Technology Ventures Limited, a 100% subsidiary of IP Group plc.

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

Based on 27,063,284 Ordinary Shares in issue

14. Contact name:

Greg Smith

15. Contact telephone number:

0207 444 0050

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLBJMATMBTBBTR
Date   Source Headline
7th Jan 20217:00 amRNSIssue of Equity
24th Dec 20207:00 amRNSIXICO secures new contract for £3.4 million
14th Dec 202011:54 amRNSHolding(s) in Company
8th Dec 20207:00 amRNSIXICO contract with new large global pharma
3rd Dec 20202:06 pmRNSSecond Price Monitoring Extn
3rd Dec 20202:01 pmRNSPrice Monitoring Extension
2nd Dec 20207:00 amRNSFinancial Results for the year ended 30 Sept 2020
27th Nov 20207:00 amRNSIXICO announces £1.9 million new study award
9th Nov 20207:00 amRNSNotice of Results
3rd Nov 20207:00 amRNSAdditional Alzheimer’s disease contracts
22nd Oct 20207:00 amRNSFurther Huntington’s disease contracts
19th Oct 20207:00 amRNSIXICO to Present at SCA & ARCA Global Conference
19th Oct 20207:00 amRNSTrading Update for year ended 30 September 2020
16th Oct 20207:00 amRNSIXICO and NYU Langone Health sign agreement
30th Sep 20202:05 pmRNSSecond Price Monitoring Extn
30th Sep 20202:00 pmRNSPrice Monitoring Extension
29th Sep 20207:00 amRNS>£2m contract extension win - Huntington’s disease
24th Sep 20207:00 amRNSCollaboration with TRACK-FA NeuroimagingConsortium
21st Sep 20207:00 amRNSIXICO selected to support Alzheimer’s trial
11th Sep 202010:36 amRNSHolding(s) in Company
26th Aug 202011:55 amRNSInvestor presentation
24th Aug 20209:05 amRNSSecond Price Monitoring Extn
24th Aug 20209:00 amRNSPrice Monitoring Extension
24th Aug 20207:00 amRNSTrading Update
13th Aug 20207:00 amRNSInvestor Presentation
8th Jul 20207:00 amRNSConference attendance - On Helix Digital
6th Jul 20207:00 amRNSGrant of share options
24th Jun 20207:00 amRNSTrading Update
20th May 20207:00 amRNSHalf yearly report to 31 March 2020
12th May 20207:00 amRNSNotice of Results
20th Apr 20207:00 amRNSTrading update for H1 2020
14th Apr 20207:00 amRNS£10.5m contract win, update on trading & COVID-19
16th Mar 20209:00 amRNSIXICO announces expanded contract with Vaccinex
2nd Mar 202011:05 amRNSSecond Price Monitoring Extn
2nd Mar 202011:00 amRNSPrice Monitoring Extension
26th Feb 202011:05 amRNSSecond Price Monitoring Extn
26th Feb 202011:00 amRNSPrice Monitoring Extension
19th Feb 20209:00 amRNSIXICO to Present AI Segmentation Research
17th Feb 20204:40 pmRNSSecond Price Monitoring Extn
17th Feb 20204:35 pmRNSPrice Monitoring Extension
17th Feb 20202:05 pmRNSSecond Price Monitoring Extn
17th Feb 20202:00 pmRNSPrice Monitoring Extension
11th Feb 20207:00 amRNSHolding(s) in Company
10th Feb 20209:11 amRNSIXICO to Present at Innovation Forum
3rd Feb 20209:00 amRNSIXICO Supports the AD Neuroimaging Initiative
23rd Jan 20207:00 amRNSDirector/PDMR Shareholding
17th Jan 20204:34 pmRNSResult of AGM
15th Jan 202010:32 amRNSDirector/PDMR Shareholding
13th Jan 20201:29 pmRNSIssue of Equity
23rd Dec 20197:00 amRNSIXICO announces updates to client contracts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.